BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12874472)

  • 1. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice.
    Makhlouf L; Yamada A; Ito T; Abdi R; Ansari MJ; Khuong CQ; Winn HJ; Auchincloss H; Sayegh MH
    J Am Soc Nephrol; 2003 Aug; 14(8):2168-75. PubMed ID: 12874472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles.
    Xu BY; Yang H; Serreze DV; MacIntosh R; Yu W; Wright JR
    Transplantation; 2005 Aug; 80(3):402-9. PubMed ID: 16082337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
    Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
    Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
    Coulombe M; Yang H; Wolf LA; Gill RG
    J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
    He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
    Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
    Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
    Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.
    Besançon A; Demir Z; Goncalves T; Valette F; Panafieu E; Chatenoud L; You S
    Transplantation; 2018 Sep; 102(9):1496-1504. PubMed ID: 29757902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.